Edition:
India

People: Albireo Pharma Inc (ALBO.OQ)

ALBO.OQ on NASDAQ Stock Exchange Capital Market

18.24USD
15 Nov 2019
Change (% chg)

-- (--)
Prev Close
$18.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,083
52-wk High
$38.48
52-wk Low
$16.26

Cooper, Ronald 

Mr. Ronald Harold Wilfred Cooper is the President, Chief Executive Officer, Director of Albireo Pharma Inc. Mr. Cooper served as President and Chief Executive Officer of Albireo Limited from July 2015 until November 2016 and has served as a director of Albireo Limited since September 2015. Prior to joining Albireo, Mr. Cooper worked for over 25 years in successive leadership roles at Bristol-Myers Squibb Company, a global biopharmaceutical company. Most recently, at Bristol-Myers Squibb Company, Mr. Cooper served as President, Europe from May 2010 until November 2015; President, Northern and Central Europe from April 2009 until April 2010; and Senior Vice President and General Manager, EU Markets from January 2008 until March 2009. Previously, Mr. Cooper held multiple senior roles in the U.S. and other countries. Mr. Cooper has served on the board of directors of Genocea Biosciences, Inc., a publicly traded biopharmaceutical company, since June 2016. Mr. Cooper earned his Bachelor's degree in Chemistry and Business Administration from St. Francis Xavier University in Canada.

Basic Compensation

Total Annual Compensation, USD 530,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 3,088,630
Fiscal Year Total, USD 3,618,630

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Chiswell

195,084

Ronald Cooper

3,618,630

Simon Harford

--

Jan Mattsson

1,404,280

Martha Carter

1,243,480

Patrick Horn

--
As Of  31 Dec 2018